Medella Therapeutics Ltd.

About:

Medella Therapeutics Ltd. develops monoclonal antibody drugs to stop cancer tumor growth.

Top Investors: Fusion IP

Description:

Medella Therapeutics, a spinout company from the University of Sheffield, is developing new cancer treatments using monoclonal antibodies – proteins made by the immune system that bind to a single target, such as a cancer cell – that have fewer side effects than many other therapies.